NASDAQ:RPTP - Raptor Pharmaceutical Stock Price, Forecast & News Notice: This company has been marked as potentially delisted and may not be actively trading. Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Raptor Pharmaceutical Corp Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume1.42 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Raptor Pharmaceutical Corp. (Raptor) is a biopharmaceutical company. The Company is focused on developing and commercializing transformative treatments for people affected by diseases. Its product, PROCYSBI (cysteamine bitartrate) is a delayed-release capsules for the management of nephropathic cystinosis in adults and children of over six years. In Europe, PROCYSBI gastro-resistant hard capsules of cysteamine (as mercaptamine bitartrate), is indicated as an orphan medicinal product for the management of nephropathic cystinosis. Read More… Industry, Sector and Symbol Stock Exchange NASDAQ Industry N/A Sub-IndustryBiotechnology SectorN/A Current SymbolNASDAQ:RPTP Previous Symbol CUSIP75382F10 CIK1070698 Webhttp://www.horizonpharma.com/ Phone+1-415-4086200Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableOptionable Receive RPTP News and Ratings via Email Sign-up to receive the latest news and ratings for RPTP and its competitors with MarketBeat's FREE daily newsletter. Raptor Pharmaceutical (NASDAQ:RPTP) Frequently Asked Questions What is Raptor Pharmaceutical's stock symbol? Raptor Pharmaceutical trades on the NASDAQ under the ticker symbol "RPTP." Has Raptor Pharmaceutical been receiving favorable news coverage? News articles about RPTP stock have been trending extremely negative recently, according to InfoTrie. The research firm scores the sentiment of news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Raptor Pharmaceutical earned a news sentiment score of -5.0 on InfoTrie's scale. They also assigned news headlines about the biotechnology company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View News Stories for Raptor Pharmaceutical. Who are some of Raptor Pharmaceutical's key competitors? Some companies that are related to Raptor Pharmaceutical include Amgen (AMGN), Gilead Sciences (GILD), Celgene (CELG), Vertex Pharmaceuticals (VRTX), Biogen (BIIB), Regeneron Pharmaceuticals (REGN), Alexion Pharmaceuticals (ALXN), Seattle Genetics (SGEN), Incyte (INCY), BioMarin Pharmaceutical (BMRN), Alnylam Pharmaceuticals (ALNY), EXACT Sciences (EXAS), Neurocrine Biosciences (NBIX), Ionis Pharmaceuticals (IONS) and Exelixis (EXEL). What other stocks do shareholders of Raptor Pharmaceutical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Raptor Pharmaceutical investors own include Opko Health (OPK), BioCryst Pharmaceuticals (BCRX), Freeport-McMoRan (FCX), NovaBay Pharmaceuticals (NBY), Achillion Pharmaceuticals (ACHN), Alnylam Pharmaceuticals (ALNY), Arrowhead Pharmaceuticals (ARWR), bluebird bio (BLUE), Celgene (CELG) and Intercept Pharmaceuticals (ICPT). What is Raptor Pharmaceutical's official website? The official website for Raptor Pharmaceutical is http://www.horizonpharma.com/. How can I contact Raptor Pharmaceutical? Raptor Pharmaceutical's mailing address is 7 Hamilton Lndg Ste 100, NOVATO, CA 94949-8283, United States. The biotechnology company can be reached via phone at +1-415-4086200. MarketBeat Community Rating for Raptor Pharmaceutical (NASDAQ RPTP)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 262 (Vote Outperform)Underperform Votes: 276 (Vote Underperform)Total Votes: 538MarketBeat's community ratings are surveys of what our community members think about Raptor Pharmaceutical and other stocks. Vote "Outperform" if you believe RPTP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RPTP will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/18/2020 by MarketBeat.com StaffFeatured Article: Forex
